Assessment and Management of Cancer-Related Cognitive Impairment
Authors:
- 1 June 2026
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in American Society of Clinical Oncology Educational Book
- Vol. 46 (3) , e517676
Abstract
Cancer-related cognitive impairment (CRCI) is common and multifactorial in nature with the cancer itself, various treatment modalities, as well as socioenvironmental, biobehavioral, and lifestyle factors all potentially contributing to cognitive impairment in cancer survivors. Estimates of CRCI prevalence vary widely depending on cancer type and the cognitive assessment tools used, but range from 25% to 75%. CRCI typically affects memory, processing speed, attention, and executive function. Diagnosis can be challenging because of a poor association between self-reported cognitive symptoms and performance on standardized neuropsychological assessment. Patient-reported outcome measures are used to assess cognitive symptoms. A comprehensive interview and history-taking by a psychologist or neuropsychologist identifies additional cognitive risk factors and comorbidities, combined with standardized neuropsychological testing, with results compared with normative data. This process evaluates cognitive skills and impairments, including specific affected cognitive domains. Based on the results and the individual concerns of the cancer survivor, tailored management strategies for cognitive impairments can be developed, including advice and support for returning to study or work. There is still inconsistent evidence for the use of pharmacologic agents for CRCI. Education about CRCI and compensatory and supportive strategies may be helpful. Brain training programs have been shown to assist with cognitive symptoms, with variable results for objective cognitive function. Cognitive rehabilitation studies (computer-based training and/or compensatory strategy training) report some improvements in certain studies on some objective cognitive measures, generally memory, as well as improvements in cognitive symptoms. Tai Chi and Qigong have also been found helpful for cognitive symptoms. Lifestyle changes, including a healthy diet, regular exercise, stress management, and addressing sleep disturbances, should be considered.Keywords
This publication has 95 references indexed in Scilit:
- Characterizing Cancer‐Related Cognitive Impairment Among Adolescent and Young Adult Cancer Survivors: Comparison to Individuals Without CancerCancer Medicine, 2025
- Post‐diagnosis smoking habit change and incident dementia in cancer survivorsAlzheimer's & Dementia, 2024
- Late-onset Cognitive Impairment and Modifiable Risk Factors in Adult Childhood Cancer SurvivorsJAMA Network Open, 2023
- A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effectsCancer Medicine, 2023
- Cognitive impairment in adolescent and young adult cancer patients: Pre‐treatment findings of a longitudinal studyCancer Medicine, 2022
- Association between body mass index at diagnosis and outcomes in Chinese children with newly diagnosed acute lymphoblastic leukemiaCancer Medicine, 2022
- Cancer-Related Cognitive Impairment in Patients With a History of Breast CancerJAMA, 2021
- Associations between coronary heart disease and risk of cognitive impairment: A meta‐analysisBrain and Behavior, 2021
- Childhood Neurotoxicity and Brain Resilience to Adverse Events during AdulthoodAnnals of Neurology, 2020
- Association of Bacteremic Sepsis With Long-term Neurocognitive Dysfunction in Pediatric Patients With Acute Lymphoblastic LeukemiaJAMA Pediatrics, 2018